Search alternatives:
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
481
-
482
-
483
Results for K<sub>s</sub>/D = 8.8 × 10<sup>−5</sup>, (a) Power, (b) Frequency, and (c) Amplitude.
Published 2025Subjects: -
484
Results for K<sub>s</sub>/D = 5.08 × 10<sup>−4</sup>, (a) Power, (b) Frequency, and (c) Amplitude.
Published 2025Subjects: -
485
-
486
-
487
FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma.
Published 2019“…<p>(A) HuH6 cells (2.5 x 10<sup>6</sup> cells in 25% Matrigel) were injected subcutaneously into the right flank of 6-week-old female athymic nude mice. …”
-
488
-
489
-
490
-
491
APB5, but not APA5, decreases apoptosis in alveolar epithelial cells in lungs of BLM-treated mice.
Published 2018“…The administration of APA5 did not change the number of TUNEL-positive cells from that in BLM-treated mice, whereas that of APB5 significantly decreased them. …”
-
492
Different response of visASCs to a micro-local oxygen concentration decrease in metabolically active sites of the adipose tissue.
Published 2017“…However, hypox-visASCs from MS patients show a lower ability to actively participate in or stimulate the formation of microvascular structures, while they favor the accumulation of CD11C<sup>+</sup> and CD163<sup>+</sup> macrophages in the adipose tissue through their contribution to the increased tissue levels of MCP1. ↑ Increased response; <b>↓</b> Decreased response; → Hypox-visASCs main response NonMS: obese subjects without metabolic syndrome; MS: obese subjects with metabolic syndrome; visASC: visceral adipose tissue-derived multipotent mesenchymal cells; hypox-visASCs: visASC under hypoxia; NOX5: NADPH Oxidase 5; SDF1α: stromal cell-derived factor 1α; VEGF: vascular endothelial growth factor; MCP1: monocyte chemoattractant protein 1; CD11C<sup>+</sup>, CD163<sup>+</sup>: proinflammatory macrophage cell-surface markers.…”
-
493
-
494
-
495
-
496
-
497
-
498
Decreased dissemination and parasite load after adoptive transfer of <i>Toxoplasma</i>-infected DC treated with GABAergic inhibitors.
Published 2012“…Data are from one set of mice and representative of two independent experiments with three to five mice per group. (<b>B</b>) Total photon emission analysis from individual mice on days 1–5 post inoculation showed a decrease in parasite tissue burden in mice inoculated with GAD and GAT4 inhibitor-treated DC infected with <i>T. gondii</i> when compared with burdens from mice inoculated with untreated DC infected with <i>T. gondii</i>. …”
-
499
Blocking CD88 decreased ANCA antigen translocation, ANCA-induced respiratory burst and degranulation in C5a-primed neutrophils.
Published 2013“…B: blocking CD88 decreased C5a-primed neutrophils expression of membrane-bound PR3 (mPR3). …”
-
500